Publicacións (46) Publicacións de JOSE ANGEL FONTENLA GIL

2024

  1. Gamma-Decanolactone Increases Stress Resistance and Improves Toxicity Parameters on the Caenorhabditis elegans Alternative Model

    Journal of Applied Toxicology

  2. Toxicological assessment of the Achyrocline satureioides aqueous extract in the Caenorhabditis elegans alternative model

    Journal of Toxicology and Environmental Health - Part A: Current Issues, Vol. 87, Núm. 18, pp. 730-751

2023

  1. 8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin's antidepressant profile: Synthesis, biological evaluation and docking studies

    European Journal of Medicinal Chemistry, Vol. 248

2021

  1. Gamma-decanolactone: Preliminary evaluation as potential antiparkinsonian drug

    European Journal of Pharmacology, Vol. 906

2020

  1. Discovery and optimization of 3-thiophenylcoumarins as novel agents against Parkinson's disease: Synthesis, in vitro and in vivo studies

    Bioorganic Chemistry, Vol. 101

  2. Gamma-decanolactone attenuates acute and chronic seizures in mice: a possible role of adenosine A1 receptors

    Behavioural pharmacology, Vol. 31, Núm. 6, pp. 544-552

  3. Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson's disease therapy

    Bioorganic Chemistry, Vol. 104

2018

  1. Alkaloids as MAO-A inhibitors: Towards the final solution for depression and anxiety

    Psychiatric and Mood Diseases and the Natural Compounds: An Approach to the Future Medical Tool (Nova Science Publishers, Inc.), pp. 169-192

2017

  1. Aporphine alkaloids and their antioxidant medical application: From antineoplastic agents to motor dysfunction diseases

    Current Organic Chemistry, Vol. 21, Núm. 4, pp. 342-347

  2. MAO inhibitory activity of bromo-2-phenylbenzofurans: Synthesis,: in vitro study, and docking calculations

    MedChemComm, Vol. 8, Núm. 9, pp. 1788-1796

2016

  1. Neuropharmacological effects of the ethanolic extract of Sida acuta

    Brazilian Journal of Pharmacognosy, Vol. 26, Núm. 2, pp. 209-215

2015

  1. Anxiolytic-like effects of 7H-benzo[e]perimidin-7-one derivatives through elevated plus-maze test in mice

    Current Topics in Medicinal Chemistry, Vol. 15, Núm. 17, pp. 1750-1754

2014

  1. Comparison of the antidepressive effects of trans-resveratrol and 5-methoxy-7H-dibenzo[de,h]quinolin-7-one.

    Current topics in medicinal chemistry, Vol. 14, Núm. 2, pp. 234-238

  2. Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases

    Future Medicinal Chemistry, Vol. 6, Núm. 4, pp. 371-383

2013

  1. Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: Synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study

    European Journal of Medicinal Chemistry, Vol. 63, pp. 151-161

2008

  1. ANXIOLYTIC/HYPNOTIC AND MIORRELAXANT ACTIVITIES OF AZEPINE DERIVATIVES

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

  2. HOMOCYSTINE-INDUCED DAMAGE IN DOPAMINERGIC NIGROSTRIATAL PATHWAYS

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

2003

  1. New arylpiperazine derivatives with high affinity for α1A, D2 and 5-HT2A receptors

    Bioorganic and Medicinal Chemistry Letters, Vol. 13, Núm. 2, pp. 175-178

  2. Synthesis of glycosyl derivatives as dopamine prodrugs: Interaction with glucose carrier GLUT-1

    Organic and Biomolecular Chemistry, Vol. 1, Núm. 5, pp. 767-771

2000

  1. Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy- 2,3,12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands

    Journal of Medicinal Chemistry, Vol. 43, Núm. 4, pp. 599-608